Walter Narajowski has joined the board of MDxHealth, the firm said. Currently senior vice president and general manager of Roka Bioscience, he has more than 25 years of experience in the medical diagnostics industry. Before Roka, Narajowski was CEO of Pathway Diagnostics, which was acquired by Quest Diagnostics in 2008. He has spent most of his career at Abbott Laboratories where he held various positions, including vice president, GM of critical care products; VP, GM of the infusion pump business; and GM of physician office diagnostics.
The company also announced that Mark Myslinksi has stepped down from its board after five years.